Tranexamic Acid for Hyperfibrinolytic Hemorrhage During Conservative Management of Placenta Percreta
- 1 November 2015
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 126 (5), 1012-1015
- https://doi.org/10.1097/aog.0000000000000915
Abstract
Isolated hyperfibrinolysis is a potential cause of bleeding during conservative management of placenta increta and percreta. Management of this treatment approach should include hemostasis monitoring, because hyperfibrinolysis can be successfully controlled using fibrinolysis inhibitors.Keywords
This publication has 7 references indexed in Scilit:
- Management of placenta percreta: a review of published casesActa Obstetricia et Gynecologica Scandinavica, 2013
- Maternal outcome after conservative management of placenta percreta at caesarean section: A report of three cases and a review of the literatureAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2013
- Tranexamic AcidDrugs, 2012
- Maternal Outcome After Conservative Treatment of Placenta AccretaObstetrics & Gynecology, 2010
- Diagnosis, Treatment and Application of Color Doppler in Conservative Management of Abnormally Adherent PlacentaUltraschall in der Medizin - European Journal of Ultrasound, 2008
- Abnormal placentation: Twenty-year analysisAmerican Journal of Obstetrics and Gynecology, 2005
- Distribution of annexin I and II in term human fetal membranes, decidua and placentaPlacenta, 1996